表纸
市场调查报告书

皮肤科学相关的各种合作契约:契约条件·协定内容

Global Dermatology Partnering 2014-2020: Deal trends, players and financials

出版商 Current Partnering, a division of Wildwood Ventures Limited 商品编码 253250
出版日期 内容资讯 英文 400+ Pages
商品交期: 最快1-2个工作天内
价格
皮肤科学相关的各种合作契约:契约条件·协定内容 Global Dermatology Partnering 2014-2020: Deal trends, players and financials
出版日期: 2020年10月01日内容资讯: 英文 400+ Pages
简介

本报告提供过去数年的皮肤科学相关的各种合作相关契约调查分析,提供近几年的各种契约趋势,大规模契约及大医药品经营者的契约概要,契约区分·开发现阶段·技术区分·各种类适应症的名录等汇整资料,为您概述为以下内容。

摘要整理

第1章 简介

第2章 皮肤科学相关的各种契约趋势

  • 简介
  • 过去数年的皮肤科学相关的合作
  • 大制药公司的契约活动
  • 对皮肤科学相关产业不甚积极的大型制药公司
  • 皮肤科学相关的合作:各类型契约
  • 皮肤科学相关的合作:各产品部门
  • 皮肤科学相关的合作:各开发阶段
  • 皮肤科学相关的合作:各技术类型
  • 皮肤科学相关的合作:各适应症
  • 平均契约期间
    • 预付款金
    • 目标成就报酬
    • 专利费率等

第3章 主要契约

  • 简介
  • 主要契约:各交易金额
  • 大型制药公司有关的主要契约

第4章 大制药公司的契约

  • 简介
  • 合作契约的有效利用方法
  • 企业简介

第5章 契约名录

  • 简介
  • 各类型契约
    • 资产购买
    • 权利转让
    • 大的对外授权
    • 共同开发
    • 共同R&D
    • 服务契约
    • 共同促销
    • 开发
    • 流通
    • 股票购买
    • 合资企业
    • 授权
    • 诉讼
    • 融资
    • 制造
    • 行销
    • 选择
    • 推销
    • 研究
    • 和解相关
    • 辅助许可证
    • 供给
    • 解除合同
  • 各开发阶段
    • 药物发明
    • 处方设计
    • 上市
    • 阶段I
    • 阶段II
    • 阶段III
    • 前临床
  • 各技术类型
    • 抗体
    • 化验
    • 生物学的化合物
    • 生医材料
    • 临床检验
    • 设备
    • 诊断
    • (DNA)核酸探针
    • 给药
    • 实现技术
    • 设备
    • 基因学
    • 天然产品
    • oligo核苷酸
    • 稀少药
    • 胜肽
    • 流程
    • 重组的DNA
    • 再生医疗
    • 研究服务
    • 研究支援
    • 筛检
    • 小分子
    • 干细胞

第6章 各适应症

  • 简介
    • 皮肤科学
    • 粉刺
    • 光线(性)角化症
    • 血管性水肿
    • 烧伤
    • 蜂窝性组织炎
    • 美容
    • 皮肤炎
    • 糖尿病性脚溃疡
    • 湿疹
    • 毛发疾病
    • 脓痂疹
    • 瘙痒
    • 指甲疾病
    • 干癣
    • 酒糟
    • 晒伤
    • 皮疹
    • 伤痕
    • 静脉溃疡
    • 创伤治疗
    • 皱纹

第7章 合作机会

  • 网路伙伴合作
  • 合作伙伴活动
  • 相关资料

附录

图表

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: CP2216

The Global Dermatology Partnering 2014-2020 report provides comprehensive understanding and unprecedented access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies

The Global Dermatology Partnering 2014-2020: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Dermatology partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Dermatology partnering agreement structure

Dermatology partnering contract documents

Top Dermatology deals by value

Most active Dermatology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of dermatology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dermatology dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading dermatology deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active dermatology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to dermatology deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dermatology partnering deals by specific dermatology target announced since 2014. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Global Dermatology Partnering 2014-2020 is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.

Global Dermatology Partnering 2014-2020 includes:

  • Trends in dermatology dealmaking in the biopharma industry since 2014
  • Analysis of dermatology deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to over 600 dermatology deal records
  • The leading dermatology deals by value since 2014
  • The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.

In Global Dermatology Partnering 2014-2020, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Dermatology Partnering 2014-2020 report provides comprehensive access to available deals and contract documents for over 550 dermatology deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

Global Dermatology Partnering 2014 to 2020 provides the reader with the following key benefits:

  • In-depth understanding of dental deal trends since 2014
  • Access dermatology deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between dermatology partner companies
  • Comprehensive access to over 600 links to actual dermatology deals entered into by the world's biopharma companies
  • Indepth review of dermatology deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner dermatology opportunities
  • Uncover companies actively partnering dermatology opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Dermatology dealmaking

  • 2.1. Introduction
  • 2.2. Dermatology partnering over the years
  • 2.3. Dermatology partnering by deal type
  • 2.4. Dermatology partnering by industry sector
  • 2.5. Dermatology partnering by stage of development
  • 2.6. Dermatology partnering by technology type
  • 2.7. Dermatology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Dermatology partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Dermatology partnering
  • 3.3. Dermatology partnering headline values
  • 3.4. Dermatology deal upfront payments
  • 3.5. Dermatology deal milestone payments
  • 3.6. Dermatology royalty rates

Chapter 4 - Leading Dermatology deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Dermatology partnering
  • 4.3. List of most active dealmakers in Dermatology
  • 4.4. Top Dermatology deals by value

Chapter 5 - Dermatology contract document directory

  • 5.1. Introduction
  • 5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Dermatology therapeutic target

Appendices

  • Appendix 1 - Directory of Dermatology deals by company A-Z 2014 to 2020
  • Appendix 2 - Directory of Dermatology deals by deal type 2014 to 2020
  • Appendix 3 - Directory of Dermatology deals by stage of development 2014 to 2020
  • Appendix 4 - Directory of Dermatology deals by technology type 2014 to 2020
  • Further reading on dealmaking
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering
  • Table of figures
  • Figure 1: Dermatology partnering since 2014
  • Figure 2: Dermatology partnering by deal type since 2014
  • Figure 3: Dermatology partnering by industry sector since 2014
  • Figure 4: Dermatology partnering by stage of development since 2014
  • Figure 5: Dermatology partnering by technology type since 2014
  • Figure 6: Dermatology partnering by indication since 2014
  • Figure 7: Dermatology deals with a headline value
  • Figure 8: Dermatology deals with upfront payment values
  • Figure 9: Dermatology deals with milestone payment
  • Figure 10: Dermatology deals with royalty rates
  • Figure 11: Active Dermatology dealmaking activity- 2014 to 2020
  • Figure 12: Top Dermatology deals by value since 2014